"Post-traumatic immunosuppression and the possibility of their  correction"

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10233

Full metadata record

DC Field	Value	Language
dc.contributor.author	Saloxiddinov Faxriddin Baxriddinovich, Hayitov Abdurasul Abdusattorovich, Xamrayev Alisher Shoxobovich, Tuguzov Bunyod Esonovich, Ismoilov Nurhon Uralovich, Mamajonov Shavkat Toxirovich	-
dc.date.accessioned	2024-01-15T18:56:08Z	-
dc.date.available	2024-01-15T18:56:08Z	-
dc.date.issued	2023-10	-
dc.identifier.issn	2181-0842	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10233	-
dc.description.abstract	Serum concentrations of soluble activation receptors (sCD25 and sCD 95), cytokines (IL-2, IL-6,and TNF-α) were studiedin the dynamics of traumatic disease treatment. Those submitted data points out the development of posttraumatic immunosuppression in the early stages of observation, such as neutrophilic leukocytosis, relative lymphopenia, increase of sCD25 and sCD95, cytokines IL-6 and TNF-α, reduction of IL-2, which are more pronounced in patients at risk of posttraumatic complications development. Basic therapy corrects only some parameters of immunity, but the usage of polyoxidonium entirely recover affected immunological indicators. It is recommended to include polyoxidonium into basic therapy in patients with traumatic disease at early stages.	en_US
dc.publisher	Science and education	en_US
dc.subject	traumatic disease, therapy, immunocorrection, polyoxidonium, soluble receptors, cytokines	en_US
dc.title	"Post-traumatic immunosuppression and the possibility of their correction"	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
3 Science and Education Volume 4 Issue 10 (2).pdf		2.39 MB	Adobe PDF	View/Open

DSpace JSPUI